Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Diet quality is a composite clinical construct that evaluates the healthfulness of an individual's overall food intake based on its alignment with dietary guidelines and its nutrient density. It is not a discrete molecular target, receptor, or enzyme; rather, it represents a complex interaction of various nutrients and bioactive compounds with human physiology (Harvard T.H. Chan School of Public Health, 2023). High diet quality is characterized by the consumption of fruits, vegetables, whole grains, and lean proteins, which collectively influence metabolic pathways, including insulin signaling and systemic inflammatory cascades (NIH, 2022). Conversely, poor diet quality, marked by high intake of ultra-processed foods and added sugars, is a primary driver of chronic conditions such as obesity and cardiovascular disease (CDC, 2022). In the pharmaceutical industry, diet quality is treated as a critical lifestyle covariate or a clinical endpoint rather than a direct drug target, as it significantly affects the baseline metabolic environment in which therapeutic agents operate.
Not applicable; diet quality is a clinical/lifestyle metric rather than a molecular target for drug binding.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Diet quality.